You're a far better math person than me, so please

You're a far better math person than me, so please correct me if I'm wrong.

For your hypothetical, 37.66% reduction in deaths makes sense.

But I don't see how that means with 100 patients, there will be 38 (37.66) lives saved.

For this example, we have 25 LL deaths out of 130 patients, and 40 placebo deaths out of 130 patients. That placebo death count comes out to 31 (30.76) deaths per 100 patients.

So with 100 patients, instead of 31 placebo/SOC deaths, there would be a 37.66% decrease (11.58) for leronlimab, leaving you with 19 leronlimab deaths. That is roughly 12 fewer patient deaths with leronlimab for a 100-patient population.

I think you could say for every 100 deaths with placebo/SOC, 38 lives would be saved by Leronlimab. That's probably what you meant, but just making sure.